| abstract |
PHARMACEUTICAL COMPOSITION, AND USE OF POTASSIUM CHANNEL K ~ v1.3 ~ INHIBITOR IN DRUG PREPARATION. The present invention relates to methods of treating various medical conditions by administering an effective amount of at least one potassium channel inhibitor Kv1.3 or an effective amount of at least one compound that has, in addition to of its potassium Kvl .3 inhibitor properties, also CBx modulating properties and / or potassium K channel opening properties (atp), to individuals with such a need. The present invention also relates to the use of an effective amount of at least one potassium channel inhibitor Kv1.3 or an effective amount of at least one compound that has, in addition to its inhibitory properties of the Kv1.3 potassium channel, also CBx modulating properties and / or potassium K channel opening properties (atp), for the preparation of a drug for prophylaxis, treatment, delayed progression, delayed onset and / or inhibition of various medical pathologies in individuals with such a need. |